Tourmaline Bio, Inc. (TRML)
47.98
0.00 (0.00%)
USD |
NASDAQ |
Dec 09, 16:00
Tourmaline Bio Market Cap: 1.233B for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novartis AG | 251.38B |
| Merck & Co., Inc. | 240.48B |
| UnitedHealth Group, Inc. | 293.13B |
| Gilead Sciences, Inc. | 148.09B |
| Eli Lilly & Co. | 879.11B |
Market Cap Related Metrics
| Price to Book Value | 4.756 |
| Price | 47.98 |
| Earnings Yield | -7.16% |